Clinical Trial Details

TRANSFORM-HF

TRANSFORM-HF: ToRsemide compArisoN With furoSemide FORManagement of Heart Failure

Purpose/Objective

Request Additional Trial Information
Full Trial Details: ClinicalTrials.gov

Condition: Heart Failure
Study Type: Interventional
Phase: Phase III
Study Start Date: 07/11/2018
Study Completion Date: 08/14/2022

The purpose of the study is to compare the treatment strategy of torsemide versus furosemide on clinical outcomes over 12 months in patients with heart failure who are hospitalized.

NCT Number

TRANSFORM-HF

Principal Investigator(s)

Geetha Pinto, MD

Sponsor(s)

Duke University

Participant Eligibility

• Age: 18 - 80
• Gender: Male, Female